Stem Cell Therapy for Cardiovascular Diseases: Where Are We Now? Phạm Mạnh Hùng, MD. PhD. FACC. FESC Director, Cardiac Cath. Lab. Vietnam Heart Institute Our practical case  M, 47 yrs  Acute anterior MI  Successful Primary PCI at 7 hours  NYHA: III  Echo after 3 days: EF 35% Our practical case What to do next? The Heart is a Regenerating Organ Activation of Endogenous Regeneration by Bone Marrow – Derived Cell Cell Therapy in Cardiovascular Diseases  Acute Myocardial Infarction  Refractory Angina  Peripheral Artery Disease  Chronic post-infarction Heart Failure Cell Therapy in Cardiovascular Diseases Acute Myocardial Infarction  Refractory Angina  Peripheral Artery Disease  Chronic post-infarction Heart Failure Cell Therapy in Acute MI: Therapeutic Target